Cadrenal Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $4.91-$20.39 |
Market Cap | $19.4M |
Shares Short | 56,472 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$8.72 |
News
See moreYahoo Finance • 3 months ago
Cadrenal Therapeutics to Conduct Partnering and Investor Meetings During the J.P. Morgan 44th Annual Healthcare Conference in San Francisco on January 12-15, 2026
Yahoo Finance • 4 months ago
Cadrenal Therapeutics CEO, Quang X. Pham, Receives BioFlorida’s Executive of the Year Award
Yahoo Finance • 4 months ago
Cadrenal Therapeutics GAAP EPS of -$1.31 beats by $0.18
Yahoo Finance • 4 months ago
Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
About
CEO | Mr. Quang X. Pham |
CFO | Mr. Matthew K. Szot CPA |
Address | 822 A1A North, Ponte Vedra, FL, United States, 32082 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |
